Navari, R. M., & Mosier, M. C. (2019). Crossover safety study of aprepitant: 2-min injection vs 30-min infusion in cancer patients receiving emetogenic chemotherapy. Onco Targets Ther.
শিকাগো স্টাইলে সাইটেশনNavari, Rudolph M., এবং Michael C. Mosier. "Crossover Safety Study of Aprepitant: 2-min Injection Vs 30-min Infusion in Cancer Patients Receiving Emetogenic Chemotherapy." Onco Targets Ther 2019.
এমএলএ সাইটেশনNavari, Rudolph M., এবং Michael C. Mosier. "Crossover Safety Study of Aprepitant: 2-min Injection Vs 30-min Infusion in Cancer Patients Receiving Emetogenic Chemotherapy." Onco Targets Ther 2019.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.